All Products
Also known as
IIEF-5, International Index of Erectile Function-5, Five-item International Index of Erectile Function, Simplified IIEF, IIEF-5 Questionnaire, Abridged IIEF
Definition
The International Index of Erectile Function-5 (IIEF-5) is an abridged, five-item version of the original 15-item International Index of Erectile Function (IIEF) questionnaire, specifically developed as a validated diagnostic tool for the assessment of erectile dysfunction (ED) in men1. This simplified instrument was created to provide clinicians with a rapid, reliable, and patient-friendly method for diagnosing the presence and severity of erectile dysfunction in clinical practice settings2.
The IIEF-5 questionnaire focuses primarily on two critical domains of male sexual function: erectile function and intercourse satisfaction1. The five carefully selected items were chosen based on their demonstrated ability to identify the presence or absence of ED and their adherence to the National Institutes of Health’s consensus definition of erectile dysfunction1. Each question utilizes a standardized 5-point Likert scale, with responses ranging from 1 to 5, providing a total possible score range of 5 to 25 points1.
The questionnaire assesses multiple aspects of erectile function over a specified timeframe, typically the previous six months. The five domains evaluated include: confidence in achieving and maintaining an erection, frequency of erections adequate for penetration during sexual stimulation, ability to maintain erection after penetration during intercourse, difficulty in maintaining erection to completion of intercourse, and overall satisfaction with sexual intercourse attempts1.
Diagnostic interpretation of IIEF-5 scores follows established cutoff values that have been validated through extensive clinical research1. A cutoff score of 21 points provides optimal discrimination between men with and without erectile dysfunction, demonstrating excellent sensitivity (0.98) and specificity (0.88) in clinical validation studies1. The severity classification system categorizes erectile dysfunction into five distinct levels: no ED (scores 22-25), mild ED (scores 17-21), mild to moderate ED (scores 12-16), moderate ED (scores 8-11), and severe ED (scores 5-7)1.
The development and validation of the IIEF-5 involved a comprehensive study of 1,152 men, including 1,036 participants with diagnosed erectile dysfunction and 116 control subjects without ED1. Receiver operating characteristic curve analysis confirmed that the IIEF-5 functions as an excellent diagnostic test for erectile dysfunction, with substantial agreement between predicted and clinically confirmed ED classifications (weighted kappa = 0.82)1.
Clinical Context
The IIEF-5 questionnaire serves as a cornerstone diagnostic instrument in the clinical evaluation and management of erectile dysfunction across diverse healthcare settings3. Healthcare providers utilize this validated tool as part of comprehensive sexual health assessments, enabling rapid screening and severity classification of erectile dysfunction during routine clinical encounters2.
In clinical practice, the IIEF-5 is particularly valuable for patient selection criteria in various therapeutic interventions. Urologists and primary care physicians employ the questionnaire to identify candidates for pharmacological treatments, including phosphodiesterase-5 inhibitors, as well as to assess eligibility for more invasive interventions such as penile prosthesis implantation4. The standardized scoring system facilitates objective treatment outcome monitoring, allowing clinicians to quantify therapeutic response and adjust treatment protocols accordingly2.
The questionnaire plays a crucial role in surgical decision-making processes, particularly in the evaluation of patients considering penile prosthesis implantation. Baseline IIEF-5 scores help establish the severity of erectile dysfunction and provide objective documentation for insurance authorization and surgical planning4. Post-surgical follow-up assessments using the IIEF-5 enable quantitative measurement of treatment efficacy and patient satisfaction outcomes.
Research applications of the IIEF-5 extend across multiple clinical domains, including cardiovascular medicine, endocrinology, and urology. The instrument serves as a primary endpoint measure in clinical trials evaluating erectile dysfunction treatments, providing standardized outcome assessments that facilitate comparison across different therapeutic modalities2. Epidemiological studies utilize the IIEF-5 to investigate the prevalence and risk factors associated with erectile dysfunction in various populations.
The questionnaire’s clinical utility is enhanced by its demonstrated reliability across diverse patient populations and cultural contexts. Validation studies have confirmed the instrument’s psychometric properties in multiple languages and geographic regions, supporting its use in international clinical research and multicenter trials3. Electronic versions of the IIEF-5 have been validated for use in telemedicine and digital health platforms, expanding accessibility and facilitating remote patient monitoring4.
Expected clinical outcomes following IIEF-5 implementation include improved diagnostic accuracy, enhanced patient-provider communication regarding sexual health concerns, and more objective treatment monitoring capabilities2. The questionnaire’s brief format reduces patient burden while maintaining diagnostic precision, encouraging greater patient participation in sexual health assessments and treatment planning processes.